arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Hims & Hers Health, Inc.

HIMS
$31.60 ▲ +1.94 (+6.54%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
30 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Bullish
auto_awesome

Analytical Summary

Hims & Hers Health, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $7.2B
Dividend Yield
Revenue Growth 3.8%
Op. Margin -12.9%
ROIC -15.9%
FCF / Share $0.39
Trailing P/E
Price / Book 16.2x
FCF Yield 1.2%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

30-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$608.10M
↑ +3.8%
Net Income Profit after all expenses
$-92.11M
↓ -547.1%
Operating Margin Operating profit as % of sales
-12.9%
↓ -966.3% 41th
FCF / Share Free cash flow per share
$0.39
↓ -20.4%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
54
Returns
89
Cash Quality
89

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters